GCM
CASM

Goldman Capital Management’s CAS Medical Systems, Inc. CASM Stock Holding History

Goldman Capital Management’s Portfolio CASM Stock Details CASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-84,030
Closed -$113K – 26
2013
Q3 		$113K Buy
+84,030
New +$123K 0.07% 27

Other funds holding CASM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
BMI Capital New York $49.9M AUM 8.11% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
TCM
TD Capital Management Memphis, Tennessee $1.11B AUM 10.06% 1-Year Est. Return

Goldman Capital Management's CASM Position: Q4 2013 in Review

Goldman Capital Management sold out of CAS Medical Systems, Inc. (CASM) in Q4 2013, closing a stake of 84,030 shares — an estimated $113K sold.

Goldman Capital Management first reported a position in CASM in Q3 2013 and held it in 1 quarter. The position peaked at $113K in Q3 2013. 23 funds tracked by Wall St. Rank hold CASM as of Q4 2013.

  • Goldman Capital Management reported no remaining CAS Medical Systems, Inc. position as of Q4 2013 after selling out during the quarter.
  • Goldman Capital Management sold 84,030 CAS Medical Systems, Inc. shares in Q4 2013, an estimated $113K.
  • Goldman Capital Management first reported a position in CAS Medical Systems, Inc. in Q3 2013 and held it in 1 quarter.
  • Goldman Capital Management's CAS Medical Systems, Inc. position peaked at $113K in Q3 2013.
  • 23 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q4 2013.

Based on Goldman Capital Management's 13F filing for Q4 2013, filed 18 Feb 2014.